These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 29312259)
21. Tolerance and Resistance of Ciofu O; Tolker-Nielsen T Front Microbiol; 2019; 10():913. PubMed ID: 31130925 [No Abstract] [Full Text] [Related]
22. Bactericidal efficacy of atmospheric pressure non-thermal plasma (APNTP) against the ESKAPE pathogens. Flynn PB; Higginbotham S; Alshraiedeh NH; Gorman SP; Graham WG; Gilmore BF Int J Antimicrob Agents; 2015 Jul; 46(1):101-7. PubMed ID: 25963338 [TBL] [Abstract][Full Text] [Related]
23. Repurposing High-Throughput Screening Identifies Unconventional Drugs with Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa under Experimental Conditions Relevant to Cystic Fibrosis. Di Bonaventura G; Lupetti V; Di Giulio A; Muzzi M; Piccirilli A; Cariani L; Pompilio A Microbiol Spectr; 2023 Aug; 11(4):e0035223. PubMed ID: 37306577 [TBL] [Abstract][Full Text] [Related]
24. An Evaluation of the Antibacterial Properties of Tormentic Acid Congener and Extracts From Chipenzi T; Baloyi G; Mudondo T; Sithole S; Fru Chi G; Mukanganyama S Adv Pharmacol Pharm Sci; 2020; 2020():8848606. PubMed ID: 33225299 [TBL] [Abstract][Full Text] [Related]
25. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection]. Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068 [TBL] [Abstract][Full Text] [Related]
26. CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens. Saha U; Gondi R; Patil A; Saroj SD Mol Biotechnol; 2023 Jan; 65(1):1-16. PubMed ID: 35939207 [TBL] [Abstract][Full Text] [Related]
30. SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant She P; Liu Y; Xu L; Li Y; Li Z; Liu S; Hussain Z; Wu Y Front Cell Infect Microbiol; 2022; 12():858606. PubMed ID: 35372124 [No Abstract] [Full Text] [Related]
31. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients]. Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922 [No Abstract] [Full Text] [Related]
32. Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells. Brunati C; Thomsen TT; Gaspari E; Maffioli S; Sosio M; Jabes D; Løbner-Olesen A; Donadio S J Antimicrob Chemother; 2018 Feb; 73(2):414-424. PubMed ID: 29092042 [TBL] [Abstract][Full Text] [Related]
33. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo. Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436 [TBL] [Abstract][Full Text] [Related]
34. Antibacterial activity of medicinal plants against ESKAPE: An update. Bhatia P; Sharma A; George AJ; Anvitha D; Kumar P; Dwivedi VP; Chandra NS Heliyon; 2021 Feb; 7(2):e06310. PubMed ID: 33718642 [TBL] [Abstract][Full Text] [Related]
35. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant Konai MM; Haldar J ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866 [TBL] [Abstract][Full Text] [Related]
36. Non-Antimicrobial Drugs: Etodolac as a Possible Antimicrobial or Adjuvant Agent Against ESKAPE Pathogens. Pereira SG; Domingues VS; Theriága J; Chasqueira MJ; Paixão P Open Microbiol J; 2018; 12():288-296. PubMed ID: 30288184 [TBL] [Abstract][Full Text] [Related]
37. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania. Peneş NO; Muntean AA; Moisoiu A; Muntean MM; Chirca A; Bogdan MA; Popa MI Rom J Morphol Embryol; 2017; 58(3):909-922. PubMed ID: 29250670 [TBL] [Abstract][Full Text] [Related]
39. Photodynamic Inactivation of ESKAPE Group Bacterial Pathogens in Planktonic and Biofilm Cultures Using Metallated Porphyrin-Doped Conjugated Polymer Nanoparticles. Martínez SR; Ibarra LE; Ponzio RA; Forcone MV; Wendel AB; Chesta CA; Spesia MB; Palacios RE ACS Infect Dis; 2020 Aug; 6(8):2202-2213. PubMed ID: 32538610 [TBL] [Abstract][Full Text] [Related]
40. Antibacterial activities of and biofilm removal by Ablysin, an endogenous lysozyme-like protein originated from Acinetobacter baumannii 1656-2. Kim S; Jin JS; Lee DW; Kim J J Glob Antimicrob Resist; 2020 Dec; 23():297-302. PubMed ID: 33045439 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]